Author:
Amat S,Bougnoux P,Penault-Llorca F,Fétissof F,Curé H,Kwiatkowski F,Achard J-L,Body G,Dauplat J,Chollet P
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Bear HD (1998) Indications for neoadjuvant chemotherapy for breast cancer. Semin Oncol 25(2 Suppl 3): 3–12
2. Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, Zambetti M (1998) Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 16: 93–100
3. Brenin DR, Morrow M (1998) Breast-conserving surgery in the neoadjuvant setting. Semin Oncol 25(2 Suppl 3): 3–18
4. Calais G, Berger C, Descamps P, Chapet S, Reynaud-Bougnoux A, Body G, Bougnoux P, Lansac J, Le Floch O (1994) Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74: 1283–1288
5. Chan S, Friedrichs K, Noel D, Pinter T, Van Belle S, Vorobiof D, Duarte R, Gil Gil M, Bodrogi I, Murray E, Yelle L, von Minckwitz G, Korec S, Simmonds P, Buzzi F, Gonzalez Mancha R, Richardson G, Walpole E, Ronzoni M, Murawsky M, Alakl M, Riva A (1999) Prospective randomized trial of docetaxel vs doxorubicin in patients with metastatic breast cancer. The 303 study group. J Clin Oncol 17: 2341–2354
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献